A CRISPR-Cas9-mediated F0 screen to identify pro-regenerative genes in the zebrafish retinal pigment epithelium

Fangfang Lu1,2, Lyndsay L Leach1,3, Jeffrey M Gross4,5

  • 1Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, PA, 15213, USA.

Scientific Reports
|February 24, 2023
PubMed

Insights

Researchers identified key genes that regulate retinal pigment epithelium (RPE) regeneration in zebrafish using CRISPR-Cas9 screening. This study reveals new factors that could potentially restore vision loss caused by RPE damage.

Area of Science:

  • Ophthalmology
  • Regenerative Medicine
  • Genetics

Background:

  • Ocular diseases causing retinal pigment epithelium (RPE) death lead to irreversible vision loss.
  • Current treatments lack FDA-approved strategies for RPE cell restoration.
  • Zebrafish exhibit significant regenerative capabilities, offering a model to study RPE repair mechanisms.

Purpose of the Study:

  • To identify genes involved in RPE regeneration using a large-scale genetic screen.
  • To validate potential pro-regenerative factors for therapeutic applications.
  • To uncover novel mechanisms regulating RPE repair in zebrafish.

Main Methods:

  • Conducted an F0 in vivo CRISPR-Cas9-mediated screen of 27 candidate RPE regeneration genes.
  • Utilized ribonucleoprotein complexes with mutagenic guide RNAs and PCR-based genotyping.
  • Employed MATLAB-based automated quantification to assess RPE regeneration efficiency.

Main Results:

  • Identified eight positive and seven negative regulators of RPE regeneration.
  • Characterized cldn7b, revealing its role in macrophage/microglia infiltration and debris clearance during RPE regeneration.
  • Demonstrated the effectiveness of targeted F0 screens for discovering regenerative factors.

Conclusions:

  • Targeted F0 screens are a valuable tool for identifying and validating pro-regenerative factors.
  • Novel factors, such as cldn7b, play critical roles in the complex process of RPE regeneration.
  • Findings provide insights into potential therapeutic strategies for vision loss due to RPE damage.